HE

Pluristem on the way to Tel Aviv-75

Overview

Investor specializing in stem cell: “Floristem is the company that has done the most with the least clinical information”

Read the full article on Globes – click here

Read More

Related Press

Automation

Efficient support provided to pharmaceutical plant builder Biopharmax during turnkey project Read the article on…

Automation

Read the full article on YNET

Automation

Advanced insulin production facility, with integrated process control system, creates completely automated facility, which raises…